- Home
- RVPHW vs RILYL Comparison
RVPHW vs RILYL Comparison
Compare RVPHW & RILYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- RILYL
- Stock Information
- Founded
- RVPHW 2018
- RILYL N/A
- Country
- RVPHW United States
- RILYL United States
- Employees
- RVPHW N/A
- RILYL 2383
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- RILYL Investment Managers
- Sector
- RVPHW Health Care
- RILYL Finance
- Exchange
- RVPHW Nasdaq
- RILYL Nasdaq
- Market Cap
- RVPHW N/A
- RILYL N/A
- IPO Year
- RVPHW N/A
- RILYL N/A
- Fundamental
- Price
- RVPHW $0.06
- RILYL $4.25
- Analyst Decision
- RVPHW
- RILYL
- Analyst Count
- RVPHW 0
- RILYL 0
- Target Price
- RVPHW N/A
- RILYL N/A
- AVG Volume (30 Days)
- RVPHW 22.4K
- RILYL N/A
- Earning Date
- RVPHW 03-14-2025
- RILYL N/A
- Dividend Yield
- RVPHW N/A
- RILYL N/A
- EPS Growth
- RVPHW N/A
- RILYL N/A
- EPS
- RVPHW N/A
- RILYL N/A
- Revenue
- RVPHW N/A
- RILYL N/A
- Revenue This Year
- RVPHW N/A
- RILYL N/A
- Revenue Next Year
- RVPHW N/A
- RILYL N/A
- P/E Ratio
- RVPHW N/A
- RILYL N/A
- Revenue Growth
- RVPHW N/A
- RILYL N/A
- 52 Week Low
- RVPHW $0.13
- RILYL N/A
- 52 Week High
- RVPHW $0.15
- RILYL N/A
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- RILYL 39.58
- Support Level
- RVPHW N/A
- RILYL $4.87
- Resistance Level
- RVPHW N/A
- RILYL $5.83
- Average True Range (ATR)
- RVPHW 0.00
- RILYL 0.62
- MACD
- RVPHW 0.00
- RILYL -0.04
- Stochastic Oscillator
- RVPHW 0.00
- RILYL 3.67
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About RILYL B. Riley Financial Inc. Depositary Shares each representing 1/1000th in a share of 7.375% Series B Cumulative Perpetual Preferred Stock par value $0.0001
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.